[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-es-110":3,"doc-seo-164775-110":41,"doc-detail-164775-es":114},{"code":4,"msg":5,"data":6},0,"success",[7,13,17,21,25,29,33,37],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":4,"slug":12},165,1,"Template","Cartas","cartas",{"id":14,"doc_module":9,"doc_module_name":10,"category_name":15,"show_sort_weight":4,"slug":16},162,"Carteles","carteles",{"id":18,"doc_module":9,"doc_module_name":10,"category_name":19,"show_sort_weight":4,"slug":20},160,"Currículums","curriculums",{"id":22,"doc_module":9,"doc_module_name":10,"category_name":23,"show_sort_weight":4,"slug":24},161,"Facturas","facturas",{"id":26,"doc_module":9,"doc_module_name":10,"category_name":27,"show_sort_weight":4,"slug":28},164,"Formularios","formularios",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":4,"slug":32},166,"General","general-166",{"id":34,"doc_module":9,"doc_module_name":10,"category_name":35,"show_sort_weight":4,"slug":36},159,"Presentaciones","presentaciones",{"id":38,"doc_module":9,"doc_module_name":10,"category_name":39,"show_sort_weight":4,"slug":40},163,"Redes sociales","redes-sociales",{"code":4,"msg":42,"data":43},"ok",{"site_id":44,"language":45,"slug":46,"title":47,"keywords":48,"description":49,"schema_data":50,"social_meta":107,"head_meta":109,"extra_data":111,"updated_unix":113},110,"es","commentary-article-thoracic-oncology-section-march-2016-atschest-policy-statement-on-lung-cancer-screening-with-ldct","ARTICULO COMENTADO - Sección Oncología torácica, Marzo 2016 - Declaración de política ATS/CHEST sobre cribado de cáncer de pulmón con LDCT","","Guía y declaración de política ATS/CHEST para orientar a sistemas de salud y centros médicos en el desarrollo e implementación de programas de detección de cáncer de pulmón mediante tomografía computarizada de bajas dosis (LDCT). Presenta una racionalidad basada en evidencia de reducción de mortalidad en población de alto riesgo y define objetivos, métodos y resultados. Organiza la ejecución en tres fases (planificación, implementación y mantenimiento) e integra nueve elementos esenciales, con estrategias prácticas y costos necesarios para sostener un programa seguro, efectivo y sostenible.",{"@graph":51,"@context":106},[52,68,89],{"@type":53,"itemListElement":54},"BreadcrumbList",[55,59,62,65],{"item":56,"name":57,"@type":58,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":60,"name":10,"@type":58,"position":61},"https://docshare.wps.com/es/template/",2,{"item":63,"name":31,"@type":58,"position":64},"https://docshare.wps.com/es/template/general/",3,{"item":66,"name":47,"@type":58,"position":67},"https://docshare.wps.com/es/template/commentary-article-thoracic-oncology-section-march-2016-atschest-policy-statement-on-lung-cancer-screening-with-ldct/164775/",4,{"url":66,"name":47,"@type":69,"image":70,"author":75,"headline":47,"publisher":78,"fileFormat":81,"inLanguage":45,"description":49,"dateModified":82,"datePublished":83,"encodingFormat":81,"isAccessibleForFree":84,"interactionStatistic":85},"DigitalDocument",{"url":71,"@type":72,"width":73,"height":74},"https://docshare.wps.com/thumbnails/commentary-article-thoracic-oncology-section-march-2016-atschest-policy-statement-on-lung-cancer-screening-with-ldct/164775.png","ImageObject",442,249,{"name":76,"@type":77},"Quinn Holloway","Person",{"url":56,"name":79,"@type":80},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-19","2026-08-31",true,{"@type":86,"interactionType":87,"userInteractionCount":61},"InteractionCounter",{"@type":88},"ViewAction",{"@type":90,"mainEntity":91},"FAQPage",[92,98,102],{"name":93,"@type":94,"acceptedAnswer":95},"¿Cuál es el propósito de la declaración ATS/CHEST para el cribado con LDCT?","Question",{"text":96,"@type":97},"Promover la implementación exitosa de programas integrales de cribado con LDCT que sean seguros, efectivos y sostenibles para los centros que desean desarrollarlos.","Answer",{"name":99,"@type":94,"acceptedAnswer":100},"¿Cómo se estructura un programa de detección de cáncer de pulmón con LDCT según el documento?",{"text":101,"@type":97},"Debe organizarse en tres etapas: planificación, implementación y mantenimiento, considerando además nueve elementos esenciales distribuidos dentro de estas fases.",{"name":103,"@type":94,"acceptedAnswer":104},"¿Qué criterios se proponen para evaluar a los pacientes candidatos al cribado?",{"text":105,"@type":97},"Las guías CHEST y ASCO sugieren ofrecer el cribado a personas con criterios de NSLT: edad 55–74 años, fumadores en los últimos 15 años, al menos 30 paquetes/año y sin comorbilidades que limiten la expectativa de vida.","https://schema.org",{"og:url":66,"og:type":108,"og:title":47,"og:site_name":79,"og:description":49},"article",{"robots":110,"canonical":66},"index,follow",{"doc_id":112,"site_id":44},164775,1788160551,{"code":4,"msg":5,"data":115},{"doc_id":112,"user_id":116,"nickname":76,"user_avatar":117,"doc_module":9,"category_id":30,"category_name":31,"doc_title":47,"doc_description":49,"doc_content":118,"file_id":119,"file_url":120,"file_type":121,"file_size":122,"view_count":61,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":123,"language":124,"language_code":45,"site_id":44,"html_lang":45,"table_of_contents":125,"faqs":126,"seo_title":127,"seo_description":49,"update_tm":113,"read_time":61},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ARTICULO COMENTADO\nSección Oncología torácica. Marzo 2016\nAn Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice\nRevista y año: Am J Respir Crit Care Med (Oct 1, 2015) 192: 881–91\nAutores:  Renda Soylemez Wiener, Michael K. Gould, Douglas A. Arenberg, David H. Au, Kathleen Fennig, Carla R. Lamb, Peter J. Mazzone, David E. Midthun, Maryann Napoli, David E. Ost, Charles A. Powell, M. Patricia Rivera,Christopher G. Slatore, Nichole T. Tanner, Anil Vachani, Juan P. Wisnivesky, and Sue H. Yoon; on behalf of the ATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice\nATS/CHEST Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice THIS OFFICIAL POLICY STATEMENT OF THE AMERICAN THORACIC SOCIETY (ATS) AND THE AMERICAN COLLEGE OF CHEST PHYSICIANS (CHEST) WAS APPROVED BY THE ATS BOARD OF DIRECTORS, JUNE 2015, AND BY THE CHEST BOARD OF REGENTS, APRIL 2015\nAbstracs\nRationale: Annual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended by multiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs. Objectives: To promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable. Methods: The American Thoracic Society (ATS) and American College of Chest Physicians (CHEST) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. Measurements and Main Results: We address steps that sites should consider during the main three phases of developing an LDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent CHEST/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program. Conclusions: Following the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.\nIntroducción\nEn este artículo se genera una declaración para guiar a los sistemas de salud y centros médicos a establecer un programa de detección de cáncer de pulmón mediante tomografía de bajas dosis de radiación. Se abordan 9 componentes esenciales y organizados mediante planificación, implementación y mantenimiento.\nFundamento: la tomografía computarizada-bajas dosis (LDCT) de radiación anual para el cribado de cáncer de pulmón ha demostrado reducir la mortalidad del cáncer de pulmón entre los individuos de alto riesgo y ahora está recomendado por varias organizaciones.\nSin embargo, la detección mediante LDCT es compleja, y la aplicación requiere una planificación cuidadosa para garantizar que los beneficios superan a los daños. Se han proporcionado muy pocas orientaciones para desarrollar e implementar programas de cribado de cáncer de pulmón. Por este motivo es que se desarrolla esta guía.\nMétodos\nSe basaron en varias fuentes evidencia:  revisiones sistemáticas (10, 15-17), guías (2-8, 18), encuestas nacionales de las percepciones de los clínicos acerca de la implementación de la detección LDCT, evaluaci","cbCainj20me6uM7L","https://ap.wps.com/l/cbCainj20me6uM7L","docx",22316,5,"Spanish","# Introducción\n# Métodos\n# Resultados\n## Etapa de Planificación\n## ¿Qué pacientes deben ser evaluados?\n## Decisión compartida y beneficios potenciales","[{\"question\":\"¿Cuál es el propósito de la declaración ATS/CHEST para el cribado con LDCT?\",\"answer\":\"Promover la implementación exitosa de programas integrales de cribado con LDCT que sean seguros, efectivos y sostenibles para los centros que desean desarrollarlos.\"},{\"question\":\"¿Cómo se estructura un programa de detección de cáncer de pulmón con LDCT según el documento?\",\"answer\":\"Debe organizarse en tres etapas: planificación, implementación y mantenimiento, considerando además nueve elementos esenciales distribuidos dentro de estas fases.\"},{\"question\":\"¿Qué criterios se proponen para evaluar a los pacientes candidatos al cribado?\",\"answer\":\"Las guías CHEST y ASCO sugieren ofrecer el cribado a personas con criterios de NSLT: edad 55–74 años, fumadores en los últimos 15 años, al menos 30 paquetes/año y sin comorbilidades que limiten la expectativa de vida.\"}]","ARTICULO COMENTADO - Sección Oncología torácica, Marzo 2016 - Declaración de política ATS/CHEST sobre cribado de cáncer de pulmón con LDCT | DOCX"]